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Aims: To characterize the uncertainty in illness and the motivation for treatment and to evaluate the
existing relation between these variables in individuals with type 2 diabetes. Method: Descriptive, correlational
study, using a sample of 62 individuals in diabetes consultation sessions. The Uncertainty Stress Scale and the
Treatment Self-Regulation Questionnaire were used. Results: The individuals with type 2 diabetes present low
levels of uncertainty in illness and a high motivation for treatment, with a stronger intrinsic than extrinsic
motivation. A negative correlation was verified between the uncertainty in the face of the prognosis and
treatment and the intrinsic motivation. Discussion: These individuals are already adapted, acting according to
the meanings they attribute to illness. Uncertainty can function as a threat, intervening negatively in the
attribution of meaning to the events related to illness and in the process of adaptation and motivation to adhere
to treatment. Intrinsic motivation seems to be essential to adhere to treatment.
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LA INCERTIDUMBRE EN LA ENFERMEDAD Y LA MOTIVACIÓN PARA EL TRATAMIENTO EN
DIABÉTICOS TIPO 2
Objetivos: Caracterizar la incertidumbre ante la enfermedad y la motivación para el tratamiento y
evaluar la relación existente entre estas variables en diabéticos tipo 2. Método: Estudio descriptivo, correlacional,
en una muestra de 62 diabéticos atendidos en consulta. Usadas la Escala de Incertidumbre ante la Enfermedad
y la Escala de Motivación para el Tratamiento. Resultados: Los diabéticos tipo 2 presentan bajos niveles de
incertidumbre ante la enfermedad y una elevada motivación para el tratamiento, siendo la motivación intrínseca
más elevada que la extrínseca. Se verificó correlación negativa entre la incertidumbre frente al pronóstico y
tratamiento y la motivación intrínseca para el tratamiento. Discusión: Estos pacientes se encuentran adaptados
actuando en conformidad con los significados que atribuyen a la enfermedad. La incertidumbre puede funcionar
como amenaza interfiriendo negativamente en la atribución de significados de los acontecimientos relacionados
con la enfermedad y con el proceso de adaptación y motivación para adherirse al tratamiento. La motivación
intrínseca parece ser un aspecto fundamental en la motivación para el tratamiento.
DESCRIPTORES: incertidumbre; motivación; diabetes mellitus tipo 2
INCERTEZA NA DOENÇA E MOTIVAÇÃO PARA O TRATAMENTO EM DIABÉTICOS TIPO 2
Objectivos: Caracterizar a incerteza na doença e a motivação para o tratamento e avaliar a relação
existente entre estas variáveis, em diabéticos tipo 2. Método: Estudo descritivo, correlacional, numa amostra de
62 diabéticos atendidos em consulta. Aplicadas a Escala de Incerteza na Doença e a Escala de Motivação para o
Tratamento. Resultados: Os diabéticos tipo 2 apresentam baixos níveis de incerteza na doença e elevada
motivação para o tratamento. A motivação intrínseca é mais elevada do que a extrínseca. Existe uma correlação
negativa entre a incerteza face ao prognóstico e tratamento e a motivação intrínseca para o tratamento. Discussão:
Os resultados sugerem que estes indivíduos se encontram adaptados agindo em conformidade com os significados
que atribuem à doença. A incerteza pode funcionar como ameaça interferindo negativamente na atribuição de
significados aos acontecimentos relacionados com a doença e com o processo de adaptação e motivação para
adesão ao tratamento. A motivação intrínseca parece ser um aspecto fundamental na motivação para o tratamento.
DESCRITORES: incerteza; motivação; diabetes mellitus tipo 2
Disponible en castellano/Disponível em língua portuguesa
SciELO Brasil www.scielo.br/rlae
1 RN, Doctoral Student in Nursing Sciences, Adjunct Professor, Escola Superior de Enfermagem Dr. Ângelo da Fonseca, Portugal, e-mail: joaoapostolo@eseaf.pt;
2 RN, Medical Service III for Women and Reumatology, Portugal, e-mail: catarinaenf@hotmail.com; 3 RN, Centro de Saúde dos Olivais, Portugal, e-mail:
lennanunes@hotmail.com; 4 RN, Instituto Português de Oncologia Francisco Gentil, Coimbra Regional Oncology Center, Portugal, e-mail:
helenardomingues@hotmail.com




Health systems have to face numerous
problems. One of them is treatment abandonment or
incorrect compliance by patients with chronic illnesses
like diabetes. Lack of motivation and non-compliance
are probably the most significant causes of treatment
failure, which leads to health system dysfunctions and
increases morbidity and mortality. Literature has
reported that individuals with diabetes find it difficult to
comply with the treatment program(1) (metabolic control,
food planning, physical activity and medical treatment).
Diabetes is one of the most demanding
chronic illnesses, in both the physical and psychological
sense. Living with this illness implies adopting a lifestyle
adjusted to one’s health condition, which calls for
changes in everyday life activities and permanent
compliance with the treatment, since it is the only
way to avoid the serious complications(2).
To live with a chronic incurable illness is to
live in a state of constant uncertainty. There is more to
the challenge of adjusting to a chronic illness than the
simple biophysical adaptation to its process. In fact,
multiple adaptations are required, and the implied state
of uncertainty is a deep and personal experience(3).
Uncertainty is considered a major factor
affecting adjustment to the illness. However, few
studies have been developed to understand the long
term effects of uncertainty on chronic illnesses(3). The
performed research mainly report that this concept
has been studied in contexts of economy, decision
making, prediction, tolerance, control, stress and
ambiguity. In this sense, it is pertinent to enhance
knowledge in this underexplored field.
The concept of illness uncertainty has been
changing over time. However, there is a consensus that
it is a cognitive state in which individuals are incapable
of attributing a meaning to illness-related events. This
is observed in situations in which one is not able to
assign definite values to objects and events and/or to
precisely predict illness outcomes(4-5). These aspects can
interfere with the motivational process as well as
treatment compliance.  The illness-associated
stimuli cause reactions that are, supposedly, explained
by the uncertainty theory in four stages: the first
comprises the antecedents that generate uncertainty;
the second regards perceiving uncertainty as either a
threat or an opportunity; the third corresponds to the
coping strategies adopted to reduce the uncertainty that
is considered a threat or, on the other hand, to maintain
the uncertainty that is considered an opportunity; and,
finally, the fourth regards the state of adaptation that
results from the adopted coping strategies(3).
With respect to motivation, this concept is
defined as a group of perceived forces that make
one act, and is influenced by one’s experiences and
other external factors(6-7).
Human beings rarely act based on a single
motive. Rather, human behavior is impelled by intrinsic
and extrinsic motivations(8). Intrinsic motivation is
responsible for an individual’s participation in an activity
for the sheer pleasure of the activity, and not for a tangible
reward that could result. On the other hand, extrinsic
motivation is that through which one takes part in an
activity with the aim of obtaining a tangible reward(7-9).
Several theories attempt to describe the
motivational phenomenon. However, none are thorough
regarding the process. It is worth highlighting that despite
their diversity, the renowned approaches are not
contradictory. Rather, they are complementary and, thus,
permit understanding a certain motivational phenomenon
that, in the present study, leads to treatment compliance
or non-compliance. The theories that aim to describe
the phenomenon as well as the influencing factors include:
Leventhal’s Model of Behavior Self-Regulation, Treatment
Compliance Models and the Health Beliefs Model.
Leventhal’s Model of Behavior Self-Regulation
provides a theoretical construction/explanation that
helps to understand the factors influencing one’s
perceptions regarding illness threats, the association
between those perceptions, the descriptions of self-
reported illness symptoms, and how personal beliefs
influences one’s self-care behavior and drives one to
either promote or ignore illness threats.
According to this model, there are two active
processes in the illness: cognition, which refers to the
objective interpretation of illness threat; and emotion,
which is the subjective reaction to a threat. These parallel
processes, cognition and emotion, are interactive. For
instance, the type 2 diabetes diet implies cognitively
processing the information to understand the complex
relationship between consuming carbohydrates and
blood glucose levels. However, emotional processes
interact with sociocultural values of food and eating.
Those values come from social experience; therefore,
they might be considered more important than the
cognition process when one decides to eat food that
increases blood glucose levels, since one feels socially
obliged to do that(10).
The health beliefs model is based on the
supposition that healthy behaviors are rationally
determined by the vulnerability to health threats.
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Individuals end up assigning a value to those perceptions
that makes them believe or not in the efficacy of the
actions that lead to the improvement of their health.
Therefore, based on these beliefs, it is possible to predict
different health-associated behaviors, at the level of
either illness prevention or health promotion(11).
Compliance implies an active attitude with voluntary
and collaborative involvement of both the patient and
the health care professional, in a combined process that
aims to change patient behavior. Hence, patients comply
with the treatment or therapeutic protocol based on a
combined agreement, in which patients take part, and
which allows patients to develop an appreciation of the
importance of certain prescribed actions(12).
Individuals can notice the benefits, the
barriers, their susceptibility to, and the seriousness
of their illness. But if one assigns little importance
to one’s own health, overvaluing other areas in their
life, the degree of compliance with a proposed action
will be too low and one’s disposition toward that
action can be null, and, thus, it will not take place(13).
In this direction, the present study had the
following purposes: to describe the characteristics of
illness uncertainty and treatment motivation in type
2 diabetes patients who were attended at two Health
Centers in the Central Region of Portugal; and to
analyze the relationship between illness uncertainty
and treatment motivation in those patients.
METHOD
Type of study
This is a descriptive-correlational quantitative
study, developed with the following research question
and hypothesis:
Q1- What are the characteristics of illness uncertainty
and treatment motivation in type 2 diabetes patients?
H1- There is a relation between illness uncertainty and
treatment motivation in these patients.
Variables
The studied variables were: illness
uncertainty, which is a cognitive state in which the
individual is unable to assign a meaning to illness-
related events(4-5); and treatment motivation, which
is a group of perceived strengths that cause one to
act, influenced by one’s own experiences and other
external factors(6-7).
Sample
The sample consisted of 62 individuals, adults
and elderly, which were attended in diabetology
appointments at the Health Centers in the cities of Pombal
and Figueira da Voz, Portugal, from February 9th to April
2nd 2004. Subjects were between 43 and 84 years old,
with an average age of 67.06 years and a standard
deviation of 8.18 years. Most subjects (59.7%) were
women. In terms of marital status, 67.7% were married,
1.6% single, 6.5% divorced and 24.2% widowed.
Procedures
The instrument was administered in a sample
of individuals diagnosed with type 2 diabetes,
considering the pre-determined criteria of including
patients that came to diabetology appointments at
Health Centers of the cities Pombal and Figueira Foz,
Portugal, between February 9th and April 2nd 2004,
who had agreed to participate in the study. In view of
these criteria, 62 individuals were interviewed.
Ethical aspects
Before data collection, the research project
was approved by the Directors of both referred Health
Centers. Individuals who agreed to participate in the
research signed the free and informed consent form.
Subjects’ conditions were taken into consideration and
the researchers clarified all doubts that were presented.
Instruments
The instrument used for data collection
consists of sociodemographic questions, in addition
to part A of the Uncertainty Stress Scale (USS) and
the Treatment Motivation Scale (TMS).
The USS(14) comprises three parts. In part A,
individuals are asked to classify their degree of uncertainty
in areas regarding their health condition and coping with
uncertainty. In part B, participants are asked to classify
their stress level related to uncertainty. Part C comprises
a 10 cm analogical visual scale that measures overall
uncertainty, stress, threat, and the perception of aspects
corresponding to the state of uncertainty.
The Portuguese version(14) of the USS, called
Illness Uncertainty Scale (IUS), which was used in
this study, consists only of part A of the original version.
It is a 5-points self-answered Likert scale,
containing 24 items, which evaluates the illness in
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terms of prognosis, treatment and coping with
uncertainty. Five answer possibilities are given: 0 - I
have no uncertainty; 1- I have little uncertainty; 2- I
have uncertainty; 3- I have some uncertainty; 4- I
have much uncertainty. The respective scores are
obtained by adding up the answers to the items in
each dimension. The total uncertainty score is the
sum of the 24 items.
Regarding validity, the IUS(15) showed good
internal consistency, with Cronbach alpha values of
.72 for uncertainty toward prognosis, .70 for coping
with uncertainty, and .82 for the total scale. In the
same study(15), the IUS was administered with Zung’s
self-evaluation anxiety scale, obtaining respective
correlation values of .40, .68, and .69 for the
prognosis, treatment, coping and total uncertainty
dimensions, which may be interpreted as a argument
for the criterion validity of the IUS.
In the studied patient sample, the IUS
showed good internal consistency, with Cronbach
alpha values of .81, .73, and .87, respectively, for
prognosis and treatment, coping, and total
uncertainty. Correlation values between the item
and the total score of each sub-scale and the total
score were above .30, except for items 1 and 23,
whose values were .23 and .24.
The TMS used in this study results from an
adaptation of the Treatment Self-Regulation
Questionnaire (TRSQ) for diabetes, which was
developed to explain the Self-Determination
Theory(16). This is a theory based on human motivation
and has been adapted to several situations in the
promotion of healthy life habits, namely weight loss
and physical exercises in the long term, keeping adults
away from smoking and improving glucose control in
individuals with diabetes(17).
The TMS is a Likert scale composed of 19
items, of which 13 evaluate intrinsic treatment
motivation, while the other six look at extrinsic
treatment motivation. This scale aims to measure
autonomous and controlled motivations to adopt a
healthy life style regarding diabetes treatment, glucose
control and practicing exercises. Answers are organized
on a scale from 1 to 7 points, ranging from strongly
disagree to strongly agree, in which the score of each
dimension is obtained by summing the answers of
items in each dimension and by the total score.
In the study sample, the instrument showed
good internal consistency, with Cronbach alpha values
of .78, .88, and .86, respectively, for extrinsic and
intrinsic motivation, and the total. Correlation values
of the item with the score of each sub-scale and with
the scale total exceeded .39, except for item 15, whose
value is .13.
RESULTS
Regarding il lness uncertainty, the data
show reduced average values for the total and for
the dimensions, uncertainty concerning prognosis
and treatment, and coping with uncertainty,
corresponding to 1.29, 1.32, and 1.20, respectively,
and with a reduced dispersion of .63, .67 and .66
(Table 1).
Table 1 - Average values and dispersion of the
answers to items that evaluate illness uncertainty
ytniatrecnussenlligninrecnocsmetI X DS niM xaM
htlaehuoytcetedotenodevahdluocuoytahW-*1
.reilraenoitidnoc 98.1 494.1 0 4
htlaehymfotnempolevedehtgnidrageR-*2
.noitidnoc 18.1 411.1 0 4
.noitidnochtlaehtnerrucymgnidrageR-*3 29,1 172.1 0 4
htlaehymplehlliwelytshtlaehymnisegnahcfI-**4
.noitidnoc 23.1 481.1 0 4
dlotevahsrehtotahwfoesnesekamotwoH-**5
.noitidnochtlaehymtuobaem 51.1 989.0 0 3
sahtahttnemtaertehtfoycaciffeehtgnidrageR-*6
.emotdesoporpneeb 17.0 260.1 0 4
.lortnocrednusimelborphtlaehymfI-*7 93.1 464.1 0 4
.noitidnochtlaehymtuobasrehtolletottahW-**8 42.1 052.1 0 4
neebevahIsnoitanalpxetnereffidehtgnidrageR-*9
.nevig 31.1 122.1 0 4
ymhtiwerefretnilliwnoitidnochtlaehymfI-**01
.seitivitcalausuympolevedotytiliba 60.1 71.1 0 4
.smotpmysymhtiwlaedotwoH-**11 28.1 733.1 0 4
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.emplehlliwnoitautis 80.1 670.1 0 4
forotacidnielbaileraerastlusermaxeymfI-*51
.noitidnochtlaehlaerym 00.1 392.1 0 4
snoitomehtiwlaedotytilibaymgnidrageR-**61
.melborphtlaehymotdetaler 56.1 492.1 0 4
snoitomehtiwlaedotytluciffidynaevahIfI-**71
.melborphtlaehymotdetaler 17.1 273.1 0 4
evahInoitamrofniehtfoytilauqehtgnidrageR-*81
.nevigneeb 67.0 551,1 0 4
tahtstnemtaertehtllahtiwylpmocdluohsIfI-*91
.desoporpneebevah 47.0 142.1 0 4
nommocnufoecnatropmiehtsitahW-*02
.noitidnochtlaehymotsmotpmys 00.2 102.1 0 4
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.noitidnochtlaeh 59.0 423.1 0 4
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ytniatrecnuhtiwgnipoC 02.1 66.0 00.0 08.2
* items concerning the dimension uncertainty about prognosis and treatment
** items concerning the dimension coping with uncertainty
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In all the items, maximum (4) and minimum
(0) values are observed, considered in the IUS
anchors; except for item 5, in which the maximum
value presented was 3.
Although these patients showed a low degree
of illness uncertainty, they reported having more
uncertainty about symptoms (items 20, 23) and health
condition (items 1, 3) in the dimension of uncertainty
toward prognosis and treatment.
As to treatment motivation in total and in the
respective dimensions of intrinsic and extrinsic
motivation, considering the limits (1-7), high average
values were observed: 5.25, 5.63 and 4.48,
respectively. Dispersion values were .89, .97, and
1.39. Intrinsic motivation values were superior to those
of extrinsic motivation (Table 2).
Table 2 - Average values and dispersion of the
answers to items that evaluate treatment motivation
except for item 3, regarding the belief that by
complying with treatment, one will improve one’s
health, in which the minimum value presented was 3.
Although patients presented indicators of a
high degree of treatment motivation, the latter is
higher in aspects associated with maintaining healthy
life habits (dimension of intrinsic motivation)
evaluated by items 18 - “These are the best choices I
could make” - and 6 - “I feel these are the best things
I can do for myself”.
It is worth highlighting that the highest
dispersion was observed in answers to items 1 and 9,
which evaluate extrinsic motivation regarding others’
indignation in case the patient does not keep diabetes
under control.
Association between illness uncertainty and treatment
motivation
In Table 3, a negative association is observed
between illness uncertainty and treatment motivation.
This is evidenced between the intrinsic treatment
motivation dimension and illness uncertainty toward
diagnosis and treatment.
Table 3 - Association between illness uncertainty and
treatment motivation*
* items regarding the intrinsic motivation dimension
** items regarding the intrinsic motivation dimension
The data resulting from the evaluation of the
answers to the various items, according to Table 2,
show that a majority of type 2 diabetes patients present
a high degree of treatment motivation in the different
aspects.
In all items, maximum (7) and minimum (1)
values are observed, considered in the TMS anchors;
! Non-compliance with the variable normality presuppositions, through
the Kolmogorov - Smirnov test with Lilliefors’ correction.
In fact, although the association is not high,
the data suggest that the higher the uncertainty level
toward diagnosis and treatment, the lesser the
patients feel intrinsically motivated to adopt a healthy
life style concerning diabetes, glucose control and
physical activity.
DISCUSSION
In general, subjects present a low degree of
illness uncertainty and high treatment motivation.
Nonetheless, intrinsic motivation is higher than
extrinsic.
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Patients show less uncertainty regarding their
expectations toward social-family support. These
results show the family support felt by patients, which
allows them to express their emotions, which coping
strategies are centered in, and have a positive
influence on their expectations concerning the illness,
treatment and prognosis. Moreover, patients acquire
a probabilistic viewpoint, with the possibility that
positive things will take place(18).
Attention should also be given to the low
degree of uncertainty toward efficacy, compliance to
the proposed treatment, and quality of the received
information.
Concerning efficacy and treatment
compliance, results suggest that the studied patients
have already adapted to the illness, and have adopted
appropriate coping strategies to either maintain or
reduce illness uncertainty, as pointed out in stage four
of its conceptualization(4). After the initial phase, in
which patients agreed with the proposed treatment,
the next phase involves maintaining behaviors
recognized as important to keep a quality of life that
patients consider good.
Regarding the quality of the received
information, since patients are regularly followed in
medical appointments, the proximity with health care
professionals indicates that patients find answers to
their questions directly from those professionals and
consider the information they receive about their
illness and their health condition reliable. Hence, this
translates into the low degree of uncertainty patients
report.
In fact, the theory supports that the lack of
information originates uncertainty because it does not
allow patients to build a reference frame. However,
this is the only uncertainty situation that is temporary
and most easily corrected. To do this, the health care
professional should be available to correctly inform
and clarify any doubts patients may have(4).
The theory also shows that the developmental
model of treatment compliance includes three stages.
The first is the patient agreeing with the proposed
treatment, which is negotiated between the latter and
the health care professional. In the second stage
(treatment compliance), patients continuously follow
the proposed treatment and the surveillance of their
own health, regardless of any obstacles that may
hinder their treatment. The last stage regards
treatment maintenance and health surveillance, in
which patients keep the adopted measures in the
previous stages, with the aim of improving their health
and incorporating them to their life style, thus changing
new behaviors into habits(19).
This study indicates an elevated degree of
motivation regarding health improvement and
maintenance in individuals with type 2 diabetes.
Moreover, it suggests that these individuals act in
accordance with what they believe is the best thing to
do regarding their health. This is consistent with the
Health Beliefs Model, which postulates that decisions
made by patients to adopt a certain healthy behavior,
like controlling capillary glucose and exercising
regularly for instance, is due to psychological variables,
such as perceiving the benefits of certain actions.
Therefore, patients assign a certain value to those
perceptions. That assigned value makes them believe
in the efficacy of the actions that help improve their
health(13).
In this research, the lowest treatment
motivation values refer to the reasons that make
individuals behave according to what others expect
of them. Those values belong to the extrinsic
motivation dimension. Results show that these patients
appear to act more according to intrinsic than to
extrinsic motivation. However, both are important to
move patients in the sense of keeping their diabetes
under control.
Human beings are complex and rarely act
based on a single motive. An individual’s behavior in
a certain situation is based on intrinsic and extrinsic
motivations(8). However, the theory does not indicate
which, intrinsic or extrinsic, is strongest. The World
Health Organization acknowledges that access to
medication is a necessary but insufficient variable for
treatment success. Patient compliance with the
recommendations made by health care professionals
is an important variable, but economic and social
variables, as well as illness and treatment
characteristics, in addition to health professional
training, family participation and a multidisciplinary
approach are also considered important for the
efficacy of treatment compliance(20).
The study hypothesis was partially accepted.
The association between illness uncertainty and
intrinsic treatment motivation shows that patients with
greater uncertainty toward prognosis and treatment
are those less motivated to comply with the treatment
they consider effective.
The theory of illness uncertainty explains how
individuals react to illness-related stimuli and how they
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structure the meaning assigned to these events(3).
Since patients have a low uncertainty degree, it is
presumed that they have adopted coping strategies,
which humans usually use to face stress-inducing
events, appropriate to their situation, and uncertainty
is acknowledged as an opportunity to grow and
change. This aspect deserves further investigation.
Uncertainty, when understood as a threat, offers a
challenge as well as an opportunity. This opportunity
that patients have to maintain and/or improve their
health condition may lead to an increase in motivation
to comply with the treatments proposed by health
care professionals(13).
This idea is supported by problem solving
models that suggest that individuals deal with illnesses
or symptoms as they would with any other everyday
issue. That is, when facing a certain problem or a
change in their health condition, individuals are
motivated to overcome the problem and recover their
normality. Regarding health and illness, being healthy
is an individual’s normal state, hence, when illness
occurs, it is interpreted as a problem that will motivate
one to reestablish their health condition.
Therefore, patients perceive their illness as
an opportunity or as a threat. If patients perceive the
risks of certain actions and the benefits of others, they
adopt strategies and behaviors that contribute to not
worsening their health condition. Thus, it is important
for patients to actively participate in the self-care
process and comply with the proposed treatment.
As verified in this study, a high degree of
motivation implies that patients consider health- and
illness-related issues important. Moreover, patients
believe that they will reap benefits from changes
made in their life style based on health
recommendations, and thus prevent the onset of
further complications.
The higher the perceived illness susceptibility
and seriousness, the lower the illness uncertainty. That
perception is also directly related to the probability of
the decision leading to an action, which should be
based on treatment motivation(13).
Actually, in cases of chronic illnesses,
uncertainty may function as a threat to illness
adaptation, thus reducing one’s ability to adopt coping
strategies and assign meanings and values to illness-
related objects and events. This makes individuals
unable to correctly predict illness outcomes, which
negatively interferes in the process of adaptation and
motivation to comply with the treatment.
However, other variables could explain the
variation in treatment motivation. For instance, the
fact that these patients attend medical appointments
provides them with access to privileged health care.
The contact with health care services, including the
motivational and informational load provided by health
care professionals, may also be a factor to justify the
motivation values found.
Thus, it is justified to study these variables in
other samples in order to diagnose uncertainty and
treatment motivation levels, mainly in individuals who
are not followed in medical appointments.
CONCLUSION
Regarding illness uncertainty, results reveal
that most patients show a low degree of illness
uncertainty. However, patients report higher
uncertainty regarding symptoms and health condition,
both pertaining to the uncertainty toward prognosis
and treatment dimension. Lower degrees of illness
uncertainty are associated with patients having
significant others to count on, which falls in the coping
with uncertainty dimension. Low illness uncertainty is
also relatively related to treatment compliance, its
efficacy, and to the quality of information, which belong
to the uncertainty toward prognosis and treatment
dimension.
Results show that most patients present high
degrees of treatment motivation. Higher motivation
degrees were observed in the intrinsic motivation
dimension, mainly in aspects related to keeping
healthy life habits and improving and maintaining
one’s health condition. Aspects in which patients show
a lower motivation degree include the reasons that
make diabetes patients behave according to what
others expect of them, that is, aspects of extrinsic
motivation. These results show that type 2 diabetes
patients appear to act mostly according to intrinsic
rather than extrinsic motivation.
Patients with greater uncertainty feel less
motivated toward treatment, especially those with
greater uncertainty toward prognosis and treatment,
who feel less intrinsically motivated to adhere to
treatment.
Further studies should be performed on these
variables in type 2 diabetes patients, mainly in
individuals from the community, in order to evaluate
the characteristics of uncertainty toward diabetes.
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Furthermore, it would permit, through health
education actions, to reduce uncertainty and
encourage primary care patients to comply with a
permanent therapy and adaptation to the illness, thus
adopting a life style appropriate to the disease, with
a view to improving quality of life and adding years
to one’s life and life to one’s years. It is also proposed
that studies be performed concerning the relationship
between illness uncertainty, treatment motivation and
glucose control.
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